Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05446467
Status:
RECRUITING
Last Update Posted:
2024-03-26
First Post:
2022-06-30
Brief Title:
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Sponsor:
Zhejiang Provincial Peoples Hospital
Organization:
Zhejiang Provincial Peoples Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Squamous Cell Carcinoma |
Keywords: